Regentis Biomaterials Ltd. (RGNT)
NYSE · Healthcare
Regentis Biomaterials Ltd. Shareholder Equity 2023–2025
Regentis Biomaterials Ltd. annual shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Regentis Biomaterials Ltd. shareholder equity as of December 31, 2025: 4.7M, a 111.54% decrease year-over-year.
- Regentis Biomaterials Ltd. shareholder equity for 2025 were 4.7M, a 111.54% decrease from 2024.
- Regentis Biomaterials Ltd. shareholder equity for 2024 were -41.1M, a 10.46% decrease from 2023.
- Regentis Biomaterials Ltd. shareholder equity for 2023 were -45.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Regentis Biomaterials Ltd. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $5 |
| 2024 | $-41 |
| 2023 | $-46 |
Regentis Biomaterials Ltd. Shareholder Equity — FAQ
Regentis Biomaterials Ltd. (RGNT) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RGNT's shareholder equity history?
The chart and table above show Regentis Biomaterials Ltd.'s shareholder equity by year and by quarter, including the growth rate.